{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:17:21Z","timestamp":1793175441572,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013348","name":"Innosuisse - Schweizerische Agentur f\u00fcr Innovationsf\u00f6rderung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jconrel.2023.04.047","type":"journal-article","created":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:17:22Z","timestamp":1683937042000},"page":"420-438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Efficient colonic drug delivery in domestic pigs employing a tablet formulation with dual control concept"],"prefix":"10.1016","volume":"358","author":[{"given":"Viviane","family":"Doggwiler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chasper","family":"Puorger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja M.","family":"Nuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Lipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Imanidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jconrel.2023.04.047_bb0005","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1053\/j.gastro.2018.12.009","article-title":"AGA Clinical practice guidelines on the management of mild-to-moderate ulcerative colitis","volume":"156","author":"Ko","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2023.04.047_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114076","article-title":"Clinical translation of advanced colonic drug delivery technologies","volume":"181","author":"Awad","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.jconrel.2023.04.047_bb0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1021\/acs.molpharmaceut.6b00641","article-title":"Measurement of in vivo gastrointestinal release and dissolution of three locally acting mesalamine formulations in regions of the human gastrointestinal tract","volume":"14","author":"Yu","year":"2017","journal-title":"Mol. Pharm."},{"issue":"14","key":"10.1016\/j.jconrel.2023.04.047_bb0020","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.2165\/00003495-200565140-00006","article-title":"Advances in colonic drug delivery","volume":"65","author":"Basit","year":"2005","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.jconrel.2023.04.047_bb0025","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ejpb.2013.01.002","article-title":"A novel coating concept for ileo-colonic drug targeting: Proof of concept in humans using scintigraphy","volume":"84","author":"Varum","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2023.04.047_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119372","article-title":"OPTICORETM, an innovative and accurate colonic targeting technology","volume":"583","author":"Varum","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.04.047_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119379","article-title":"A dual pH and microbiota-triggered coating (PhloralTM) for fail-safe colonic drug release","volume":"583","author":"Varum","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.04.047_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118723","article-title":"In vitro and human pharmacoscintigraphic evaluation of an oral 5-ASA delivery system for colonic release","volume":"572","author":"Foppoli","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.04.047_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122055","article-title":"Targeted colonic release formulations of mesalazine \u2013 A clinical pharmaco-scintigraphic proof-of-concept study in healthy subjects and patients with mildly active ulcerative colitis","volume":"625","author":"Varum","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.04.047_bb0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2015.10.022","article-title":"Intragastric pH and pressure profiles after intake of the high-caloric, high-fat meal as used for food effect studies","volume":"220","author":"Koziolek","year":"2015","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2023.04.047_bb0055","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2036.2004.02033.x","article-title":"In vivo evaluation of a novel pH- and time-based multiunit colonic drug delivery system","volume":"20","author":"Bott","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.jconrel.2023.04.047_bb0060","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0022-3565(25)29238-2","article-title":"The role of intestinal bacteria in the metabolism of salicylazosulfapyridine","volume":"181","author":"Peppercorn","year":"1972","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2023.04.047_bb0065","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/A:1012019820603","article-title":"The use of scintigraphy to provide \u2018proof of concept\u2019 for novel polysaccharide preparations designed for colonic drug delivery","volume":"14","author":"Adkin","year":"1997","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.jconrel.2023.04.047_bb0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/10611860410001693751","article-title":"In-vitro and in-vivo evaluation of mesalazine\u2013guar gum matrix tablets for colonic drug delivery","volume":"12","author":"Tu\u011fcu-Demir\u00f6z","year":"2004","journal-title":"J. Drug Target."},{"issue":"3","key":"10.1016\/j.jconrel.2023.04.047_bb0075","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1023\/A:1022660305931","article-title":"Effect of colonic lactulose availability on the timing of drug release onset in vivo from a unique colon-specific drug delivery system (CODESTM)","volume":"20","author":"Yang","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.04.047_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122499","article-title":"Tablet formulation with dual control concept for efficient colonic drug delivery","volume":"631","author":"Doggwiler","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.04.047_bb0085","series-title":"Comprehensive Glycoscience","first-page":"613","article-title":"Storage plant polysaccharides: xyloglucans, galactomannans, glucomannans","author":"Nishinari","year":"2007"},{"key":"10.1016\/j.jconrel.2023.04.047_bb0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejpb.2015.03.009","article-title":"In-vitro simulation of luminal conditions for evaluation of performance of oral drug products: choosing the appropriate test media","volume":"93","author":"Markopoulos","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.jconrel.2023.04.047_bb0095","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/03639045.2015.1044905","article-title":"Enhanced colonic delivery of ciclosporin - A self-emulsifying drug delivery system encapsulated in coated minispheres","volume":"42","author":"Keohane","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2023.04.047_bb0100","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijpharm.2006.05.035","article-title":"In vitro release and in vivo absorption in beagle dogs of meloxicam from Eudragit\u00ae FS 30 D-coated pellets","volume":"322","author":"Gao","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.04.047_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113853","article-title":"Ingestible devices for studying the gastrointestinal physiology and their application in oral biopharmaceutics","volume":"176","author":"Weitschies","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.jconrel.2023.04.047_bb0110","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jcmgh.2016.09.003","article-title":"Large animal models: The key to translational discovery in digestive disease research","volume":"2","author":"Ziegler","year":"2016","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2023.04.047_bb0115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejpb.2019.01.026","article-title":"Characterization of the GI transit conditions in beagle dogs with a telemetric motility capsule","volume":"136","author":"Koziolek","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"7","key":"10.1016\/j.jconrel.2023.04.047_bb0120","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1002\/jps.22486","article-title":"Development of a canine model to enable the preclinical assessment of pH-dependent absorption of test compounds","volume":"100","author":"Fancher","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.04.047_bb0125","first-page":"80","article-title":"Experimental Goettingen minipig and beagle dog as two species used in bioequivalence studies for clinical pharmacology (5-aminosalicylic acid and atenolol as model drugs)","volume":"18","author":"Kvetina","year":"1999","journal-title":"Gen. Physiol. Biophys."},{"issue":"3","key":"10.1016\/j.jconrel.2023.04.047_bb0130","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.vascn.2010.05.009","article-title":"The utility of the minipig as an animal model in regulatory toxicology","volume":"62","author":"Bode","year":"2010","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"4","key":"10.1016\/j.jconrel.2023.04.047_bb0135","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/jphp.12912","article-title":"The pig as a preclinical model for predicting oral bioavailability and in vivo performance of pharmaceutical oral dosage forms: a PEARRL review","volume":"71","author":"Henze","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.jconrel.2023.04.047_bb0140","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/0300985811402846","article-title":"Swine as models in biomedical research and toxicology testing","volume":"49","author":"Swindle","year":"2011","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.jconrel.2023.04.047_bb0145","article-title":"Toward the establishment of a standardized pre-clinical porcine model to predict food effects \u2013 Case studies on fenofibrate and paracetamol","volume":"1","author":"Henze","year":"2019","journal-title":"Int. J. Pharm. X"},{"issue":"1","key":"10.1016\/j.jconrel.2023.04.047_bb0150","first-page":"105627","article-title":"Characterization of gastrointestinal transit and luminal conditions in pigs using a telemetric motility capsule","volume":"156","author":"Henze","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2023.04.047_bb0155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1079\/BJN19940108","article-title":"Comparison of the ileal and faecal digestibility of dietary amino acids in adult humans and evaluation of the pig as a model animal for digestion studies in man","volume":"71","author":"Rowan","year":"1994","journal-title":"Br. J. Nutr."},{"issue":"4","key":"10.1016\/j.jconrel.2023.04.047_bb0160","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1365-2125.2000.00164.x","article-title":"Dose loading with delayed-release mesalazine: a study of tissue drug concentrations and standard pharmacokinetic parameters","volume":"49","author":"Hussain","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.jconrel.2023.04.047_bb0165","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1007\/s11095-014-1367-6","article-title":"Pharmacokinetics of paracetamol in G\u00f6ttingen minipigs: In vivo studies and modeling to elucidate physiological determinants of absorption","volume":"31","author":"Suenderhauf","year":"2014","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2023.04.047_bb0170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1211\/0022357011775163","article-title":"Gastrointestinal transit of dosage forms in the pig","volume":"53","author":"Davis","year":"2001","journal-title":"J. Pharm. Pharmacol."},{"issue":"4","key":"10.1016\/j.jconrel.2023.04.047_bb0175","doi-asserted-by":"crossref","DOI":"10.1136\/gut.45.4.581","article-title":"Comparison of three dimensional magnetic resonance imaging in conjunction with a blood pool contrast agent and nuclear scintigraphy for the detection of experimentally induced gastrointestinal bleeding","volume":"45","author":"Hilfiker","year":"1999","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.jconrel.2023.04.047_bb0180","first-page":"56","article-title":"Intestinal performance of two mesalamine formulations in patients with active ulcerative colitis as assessed by gamma scintigraphy","volume":"27","author":"Sinha","year":"2003","journal-title":"Pr. gastroenterol"},{"issue":"5","key":"10.1016\/j.jconrel.2023.04.047_bb0185","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/jps.20063","article-title":"Scintigraphic evaluation of a novel colon-targeted delivery system (CODESTM) in healthy volunteers","volume":"93","author":"Katsuma","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.04.047_bb0190","article-title":"A pharmacokinetic and scintigraphic comparison of MMXTM mesalamine and delayed-release mesalamine: 1110","volume":"103","author":"Wray","year":"2008","journal-title":"Off. J. Am. Coll. Gastroenterol. | ACG"},{"issue":"10","key":"10.1016\/j.jconrel.2023.04.047_bb0195","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1211\/0022357991776796","article-title":"Validation of a pharmacokinetic model of colon-specific drug delivery and the therapeutic effects of chitosan capsules containing 5-aminosalicylic acid on 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats","volume":"51","author":"Tozaki","year":"1999","journal-title":"J. Pharm. Pharmacol."},{"issue":"4","key":"10.1016\/j.jconrel.2023.04.047_bb0200","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2125.1982.tb01415.x","article-title":"The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man","volume":"13","author":"Azad Khan","year":"1982","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.jconrel.2023.04.047_bb0205","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jconrel.2008.06.014","article-title":"Use of the BioDis to generate a physiologically relevant IVIVC","volume":"130","author":"Klein","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.04.047_bb0210","series-title":"Physiologically based pharmacokinetic (PBPK) modeling and simulations: principles, methods, and applications in the pharmaceutical industry","author":"Peters","year":"2021"},{"key":"10.1016\/j.jconrel.2023.04.047_bb0215","series-title":"Numerical data fitting in dynamical systems - A practical introduction with applications and software","author":"Schittkowski","year":"2002"},{"issue":"2","key":"10.1016\/j.jconrel.2023.04.047_bb0220","doi-asserted-by":"crossref","DOI":"10.1136\/gut.28.2.196","article-title":"Metabolism and urinary excretion of 5-amino salicylic acid in healthy volunteers when given intravenously or released for absorption at different sites in the gastrointestinal tract","volume":"28","author":"Myers","year":"1987","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.jconrel.2023.04.047_bb0225","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/BF01296618","article-title":"Pharmacokinetics of 5-aminosalicylic acid in man following administration of intravenous bolus and per os slow-release formulation","volume":"36","author":"Bondesen","year":"1991","journal-title":"Dig. Dis. Sci."},{"issue":"2","key":"10.1016\/j.jconrel.2023.04.047_bb0230","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2885.2002.00395.x","article-title":"Study of the plasma pharmacokinetics and faecal excretion of the prodrug olsalazine and its metabolites after oral administration to horses","volume":"25","author":"Knoll","year":"2002","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.jconrel.2023.04.047_bb0235","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1002\/jps.24485","article-title":"Two-stage single-compartment models to evaluate dissolution in the lower intestine","volume":"104","author":"Markopoulos","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.04.047_bb0240","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1590\/S1984-82502015000200022","article-title":"Development, characterization and evaluation of the dissolution profile of sulfasalazine suspensions","volume":"51","author":"da Costa","year":"2015","journal-title":"Brazilian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.04.047_bb0245","series-title":"Handbook of aqueous solubility data","author":"Yalkowsky","year":"2010"},{"issue":"1","key":"10.1016\/j.jconrel.2023.04.047_bb0250","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0378-5173(01)00958-9","article-title":"The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers","volume":"234","author":"Kamimori","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.04.047_bb0255","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejps.2018.03.017","article-title":"Exploring gastric emptying rate in minipigs: Effect of food type and pre-dosing of metoclopramide","volume":"118","author":"Henze","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.jconrel.2023.04.047_bb0260","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0090-9556(24)15210-5","article-title":"Intestinal metabolism and transport of 5-aminosalicylate","volume":"27","author":"Zhou","year":"1999","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.jconrel.2023.04.047_bb0265","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.xphs.2018.02.016","article-title":"A biopredictive in vitro comparison of oral locally acting mesalazine formulations by a novel dissolution model for assessing intraluminal drug release in individual subjects","volume":"107","author":"Karkossa","year":"2018","journal-title":"J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.jconrel.2023.04.047_bb0270","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1023\/A:1018909527659","article-title":"Evaluation of the physicochemical properties and dissolution characteristics of mesalamine: relevance to controlled intestinal drug delivery","volume":"10","author":"French","year":"1993","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.jconrel.2023.04.047_bb0275","first-page":"207","article-title":"Pharmacokinetics of oral caffeine in sows: a pilot study","volume":"21","author":"Menozzi","year":"2015","journal-title":"Large Anim. Rev."},{"issue":"7","key":"10.1016\/j.jconrel.2023.04.047_bb0280","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3109\/03602538409029964","article-title":"Interspecies comparison of in vivo caffeine pharmacokinetics in man, monkey, rabbit, rat and mouse","volume":"15","author":"Bonati","year":"1984","journal-title":"Drug Metab. Rev."},{"issue":"6","key":"10.1016\/j.jconrel.2023.04.047_bb0285","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2131\/jts.37.1157","article-title":"Simultaneous pharmacokinetics assessment of caffeine, warfarin, omeprazole, metoprolol, and midazolam intravenously or orally administered to microminipigs","volume":"37","author":"Mogi","year":"2012","journal-title":"J. Toxicol. Sci."},{"issue":"7\u20138","key":"10.1016\/j.jconrel.2023.04.047_bb0290","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/1040-830491379245","article-title":"Caffeine use in sports, pharmacokinetics in man, and cellular mechanisms of action","volume":"45","author":"Magkos","year":"2005","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.jconrel.2023.04.047_bb0295","series-title":"Methylxanthines","author":"Fredholm","year":"2010"},{"issue":"1","key":"10.1016\/j.jconrel.2023.04.047_bb0300","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00609587","article-title":"Plasma and salivary pharmacokinetics of caffeine in man","volume":"21","author":"Newton","year":"1981","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.jconrel.2023.04.047_bb0305","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3109\/00365528609011102","article-title":"Steady-state kinetics of 5-aminosalicylic acid and sulfapyridine during sulfasalazine prophylaxis in ulcerative colitis","volume":"21","author":"Bondesen","year":"1986","journal-title":"Scand. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.jconrel.2023.04.047_bb0310","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00003088-198510040-00001","article-title":"Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid","volume":"10","author":"Klotz","year":"1985","journal-title":"Clin. Pharmacokinet."},{"issue":"8","key":"10.1016\/j.jconrel.2023.04.047_bb0315","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1021\/acs.molpharmaceut.7b00095","article-title":"Magnetic resonance imaging quantification of fasted state colonic liquid pockets in healthy humans","volume":"14","author":"Murray","year":"2017","journal-title":"Mol. Pharm."},{"issue":"10","key":"10.1016\/j.jconrel.2023.04.047_bb0320","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s11095-010-0223-6","article-title":"Biorelevant media to simulate fluids in the ascending colon of humans and their usefulness in predicting intracolonic drug solubility","volume":"27","author":"Vertzoni","year":"2010","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.jconrel.2023.04.047_bb0325","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1208\/s12248-016-9953-7","article-title":"A quantitative review and meta-models of the variability and factors affecting oral drug absorption - part II: Gastrointestinal transit time","volume":"18","author":"Abuhelwa","year":"2016","journal-title":"AAPS J."},{"issue":"1","key":"10.1016\/j.jconrel.2023.04.047_bb0330","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/cs0780105","article-title":"Acetylation of 5-aminosalicylic acid by isolated human colonic epithelial cells","volume":"78","author":"Ireland","year":"1990","journal-title":"Clin. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2023.04.047_bb0335","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0016-5085(89)91412-1","article-title":"Colonic N-acetylation of 5-aminosalicylic acid in inflammatory bowel disease","volume":"97","author":"Allgayer","year":"1989","journal-title":"Gastroenterology"},{"issue":"7489","key":"10.1016\/j.jconrel.2023.04.047_bb0340","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature12907","article-title":"A discrete genetic locus confers xyloglucan metabolism in select human gut Bacteroidetes","volume":"506","author":"Larsbrink","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jconrel.2023.04.047_bb0345","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/nmo.12713","article-title":"Regional gastrointestinal transit times in severe ulcerative colitis","volume":"28","author":"Haase","year":"2016","journal-title":"Neurogastroenterol. Motil."},{"issue":"4","key":"10.1016\/j.jconrel.2023.04.047_bb0350","doi-asserted-by":"crossref","first-page":"A781","DOI":"10.1016\/S0016-5085(00)85265-8","article-title":"Gut pH and transit time in ulcerative colitis appear sufficient for complete dissolution of pH-dependent 5-ASA-containing capsules","volume":"118","author":"Nugent","year":"2000","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.jconrel.2023.04.047_bb0355","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/BF01297074","article-title":"Very low intraluminal colonic pH in patients with active ulcerative colitis","volume":"38","author":"Fallingborg","year":"1993","journal-title":"Dig. Dis. Sci."},{"issue":"4","key":"10.1016\/j.jconrel.2023.04.047_bb0360","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1264\/jsme2.ME17017","article-title":"Microbial ecology along the gastrointestinal tract","volume":"32","author":"Hillman","year":"2017","journal-title":"Microbes Environ."},{"key":"10.1016\/j.jconrel.2023.04.047_bb0365","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejps.2015.03.001","article-title":"Analysis of small intestinal transit and colon arrival times of non-disintegrating tablets administered in the fasted state","volume":"75","author":"Pi\u0161lar","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2023.04.047_bb0370","doi-asserted-by":"crossref","first-page":"12727","DOI":"10.1038\/s41598-018-30932-6","article-title":"Characterization of bacterial microbiota compositions along the intestinal tract in pigs and their interactions and functions","volume":"8","author":"Crespo-Piazuelo","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2023.04.047_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2016.02108","article-title":"Evaluating the contribution of gut microbiota to the variation of porcine fatness with the cecum and fecal samples","volume":"7","author":"He","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2023.04.047_bb0380","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.834598","article-title":"Porcine models of the intestinal microbiota: The translational key to understanding how gut commensals contribute to gastrointestinal disease","volume":"9","author":"Rose","year":"2022","journal-title":"Front. Vet. Sci."},{"issue":"9","key":"10.1016\/j.jconrel.2023.04.047_bb0385","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1002\/jps.24274","article-title":"Investigation of pH and temperature profiles in the GI tract of fasted human subjects using the Intellicap\u00ae system","volume":"104","author":"Koziolek","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.04.047_bb0390","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejpb.2016.09.009","article-title":"Resolving the physiological conditions in bioavailability and bioequivalence studies: Comparison of fasted and fed state","volume":"108","author":"Schneider","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.jconrel.2023.04.047_bb0395","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijpharm.2010.04.044","article-title":"The transit of dosage forms through the colon","volume":"395","author":"Wilson","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2023.04.047_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-012-0911-5","article-title":"A physiologically based pharmacokinetic model of the minipig: Data compilation and model implementation","volume":"30","author":"Suenderhauf","year":"2013","journal-title":"Pharm. Res."},{"issue":"11","key":"10.1016\/j.jconrel.2023.04.047_bb0405","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1023\/A:1015936426906","article-title":"Gastrointestinal transit of nondisintegrating, noneridible oral dosage forms in pigs","volume":"7","author":"Hossain","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.04.047_bb0410","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1023\/A:1018939204809","article-title":"Variability in gastric pH and delayed gastric emptying in yucatan miniature pigs","volume":"11","author":"Oberle","year":"1994","journal-title":"Basic Pharm. Res."},{"issue":"10","key":"10.1016\/j.jconrel.2023.04.047_bb0415","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1023\/A:1015855829864","article-title":"Correlation of the gastric emptying of nondisintegrating tablets with gastrointestinal motility","volume":"8","author":"Coupe","year":"1991","journal-title":"Pharm. Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923002973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923002973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T17:55:51Z","timestamp":1764870951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923002973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":83,"alternative-id":["S0168365923002973"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.04.047","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficient colonic drug delivery in domestic pigs employing a tablet formulation with dual control concept","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.04.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}